go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

MRD PHYSICOM Medical Research and Development Physicom GmbH

Organization type
RDM medtech
Region
Upper Austria
Cluster
Medical Technology Cluster
Topic
Other
Details

THI Total Healthcare Innovation GmbH

Organization type
RDM medtech
Region
Carinthia
Topic
hospital hardware
Details

Heart Regeneration Technologies GmbH

Organization type
RDM medtech
Region
Tyrol
Details

ICT Innovation in Clinical Trials GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
Medical Technology Cluster
LISAvienna
Topic
telemedicine and e-health
software for medicine
Details

Contact



Contact: